{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:16Z","timestamp":1792791016790,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12272-020-01237-y","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T14:08:43Z","timestamp":1589983723000},"page":"514-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia\/reperfusion injury through HIF-1\u03b1\/VEGF signaling pathway"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3770-7128","authenticated-orcid":false,"given":"Rania G.","family":"Abdel-latif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab A.","family":"Rifaai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Entesar F.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"1237_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3389\/fphys.2017.01077","volume":"8","author":"I Andreadou","year":"2017","unstructured":"Andreadou I, Efentakis P, Balafas E, Togliatto G, Davos CH, Varela A, Dimitriou CA, Nikolaou P-E, Maratou E, Lambadiari V (2017) Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects. Front Physiol 8:1077. https:\/\/doi.org\/10.3389\/fphys.2017.01077","journal-title":"Front Physiol"},{"key":"1237_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cbi.2017.08.013","volume":"277","author":"NM Arafa","year":"2017","unstructured":"Arafa NM, Ali EH, Hassan MK (2017) Canagliflozin prevents scopolamine-induced memory impairment in rats: comparison with galantamine hydrobromide action. Chem Biol Interact 277:195\u2013203. https:\/\/doi.org\/10.1016\/j.cbi.2017.08.013","journal-title":"Chem Biol Interact"},{"key":"1237_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","volume":"60","author":"A Baartscheer","year":"2017","unstructured":"Baartscheer A, Schumacher CA, W\u00fcst RC, Fiolet JW, Stienen GJ, Coronel R, Zuurbier CJ (2017) Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits. Diabetologia 60:568\u2013573. https:\/\/doi.org\/10.1007\/s00125-016-4134-x","journal-title":"Diabetologia"},{"key":"1237_CR4","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1523\/JNEUROSCI.0449-07.2007","volume":"27","author":"O Baranova","year":"2007","unstructured":"Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC (2007) Neuron-specific inactivation of the hypoxia inducible factor 1\u03b1 increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27:6320\u20136332. https:\/\/doi.org\/10.1523\/JNEUROSCI.0449-07.2007","journal-title":"J Neurosci"},{"key":"1237_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S2213-8587(13)70208-0","volume":"2","author":"AH Barnett","year":"2014","unstructured":"Barnett AH, Mithal A, Manassie J, Jones R, Rattunde H, Woerle HJ, Broedl UC, investigators E-RRt (2014) Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2:369\u2013384. https:\/\/doi.org\/10.1016\/S2213-8587(13)70208-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1237_CR6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/01.str.17.6.1304","volume":"17","author":"JB Bederson","year":"1986","unstructured":"Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304\u20131308. https:\/\/doi.org\/10.1161\/01.str.17.6.1304","journal-title":"Stroke"},{"key":"1237_CR7","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1046\/j.1460-9568.1999.00845.x","volume":"11","author":"M Bergeron","year":"1999","unstructured":"Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR (1999) Induction of hypoxia-inducible factor\u20101 (HIF\u20101) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 11:4159\u20134170. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00845.x","journal-title":"Eur J Neurosci"},{"key":"1237_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-51343-1","volume":"9","author":"R Bessho","year":"2019","unstructured":"Bessho R, Takiyama Y, Takiyama T, Kitsunai H, Takeda Y, Sakagami H, Ota T (2019) Hypoxia-inducible factor-1\u03b1 is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy. Sci Rep 9:1\u201312. https:\/\/doi.org\/10.1038\/s41598-019-51343-1","journal-title":"Sci Rep"},{"key":"1237_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1745-7254.2007.00514.x","volume":"28","author":"Y Chang","year":"2007","unstructured":"Chang Y, Hsiao G, Chen S-h, Chen Y-c, Lin J-h, Lin K-h, Chou D-s, Sheu J-r (2007) Tetramethylpyrazine suppresses HIF-1\u03b1, TNF-\u03b1, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats. Acta Pharmacol Sin 28:327. https:\/\/doi.org\/10.1111\/j.1745-7254.2007.00514.x","journal-title":"Acta Pharmacol Sin"},{"key":"1237_CR10","doi-asserted-by":"publisher","first-page":"e0158810","DOI":"10.1371\/journal.pone.0158810","volume":"11","author":"Y-K Chang","year":"2016","unstructured":"Chang Y-K, Choi H, Jeong JY, Na K-R, Lee KW, Lim BJ, Choi DE (2016) Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury. PLoS ONE 11:e0158810. https:\/\/doi.org\/10.1371\/journal.pone.0158810","journal-title":"PLoS ONE"},{"key":"1237_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.biocel.2004.08.012","volume":"37","author":"M-AC D\u00e9ry","year":"2005","unstructured":"D\u00e9ry M-AC, Michaud MD, Richard DE (2005) Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37:535\u2013540. https:\/\/doi.org\/10.1016\/j.biocel.2004.08.012","journal-title":"Int J Biochem Cell Biol"},{"key":"1237_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2013.04.024","volume":"1517","author":"Y Dong","year":"2013","unstructured":"Dong Y, Li Y, Feng D, Wang J, Wen H, Liu D, Zhao D, Liu H, Gao G, Yin Z (2013) Protective effect of HIF-1\u03b1 against hippocampal apoptosis and cognitive dysfunction in an experimental rat model of subarachnoid hemorrhage. Brain Res 1517:114\u2013121. https:\/\/doi.org\/10.1016\/j.brainres.2013.04.024","journal-title":"Brain Res"},{"key":"1237_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.7150\/ijms.7634","volume":"11","author":"Y-s Dong","year":"2014","unstructured":"Dong Y-s, Wang J-l, Feng D-y, Qin H-z, Wen H, Yin Z-m, Gao G-d, Li C (2014) Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int J Med Sci 11:282. https:\/\/doi.org\/10.7150\/ijms.7634","journal-title":"Int J Med Sci"},{"key":"1237_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12883-018-1086-4","volume":"18","author":"MA Erdogan","year":"2018","unstructured":"Erdogan MA, Yusuf D, Christy J, Solmaz V, Erdogan A, Taskiran E, Erbas O (2018) Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy. BMC Neurol 18:81. https:\/\/doi.org\/10.1186\/s12883-018-1086-4","journal-title":"BMC Neurol"},{"key":"1237_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1634\/theoncologist.9-suppl_1-2","volume":"9","author":"N Ferrara","year":"2004","unstructured":"Ferrara N (2004) Vascular endothelial growth factor as a target for anticancer\ntherapy. Oncologist 9:2\u201310. https:\/\/doi.org\/10.1634\/theoncologist.9-suppl_1-2","journal-title":"Oncologist"},{"key":"1237_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/01.str.26.4.627","volume":"26","author":"JH Garcia","year":"1995","unstructured":"Garcia JH, Wagner S, Liu K-F, Hu X-j (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke 26:627\u2013635. https:\/\/doi.org\/10.1161\/01.str.26.4.627","journal-title":"Stroke"},{"key":"1237_CR17","doi-asserted-by":"publisher","first-page":"e9767","DOI":"10.1371\/journal.pone.0009767","volume":"5","author":"KM Harms","year":"2010","unstructured":"Harms KM, Li L, Cunningham LA (2010) Murine neural stem\/progenitor cells protect neurons against ischemia by HIF-1\u03b1\u2013regulated VEGF signaling. PLoS ONE 5:e9767. https:\/\/doi.org\/10.1371\/journal.pone.0009767","journal-title":"PLoS ONE"},{"key":"1237_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.lfs.2011.12.001","volume":"90","author":"GH Heeba","year":"2012","unstructured":"Heeba GH, El-Hanafy AA (2012) Nebivolol regulates eNOS and iNOS expressions and alleviates oxidative stress in cerebral ischemia\/reperfusion injury in rats. Life Sci 90:388\u2013395. https:\/\/doi.org\/10.1016\/j.lfs.2011.12.001","journal-title":"Life Sci"},{"key":"1237_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13300-013-0030-2","volume":"4","author":"T Heise","year":"2013","unstructured":"Heise T, Seman L, Macha S, Jones P, Marquart A, Pinnetti S, Woerle HJ, Dugi K (2013) Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of empagliflozin in patients with type 2 diabetes mellitus. Diabetes Ther 4:331\u2013345. https:\/\/doi.org\/10.1007\/s13300-013-0030-2","journal-title":"Diabetes Ther"},{"key":"1237_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-1-4939-2917-7_12","volume":"1332","author":"VC Ho","year":"2015","unstructured":"Ho VC, Fong G-H (2015) Vasculogenesis and angiogenesis in VEGF receptor-1 deficient mice. Methods Mol Biol 1332:161\u2013176. https:\/\/doi.org\/10.1007\/978-1-4939-2917-7_12","journal-title":"Methods Mol Biol"},{"key":"1237_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/s0306-4522(00)00207-4","volume":"99","author":"K Jin","year":"2000","unstructured":"Jin K, Mao X, Nagayama T, Goldsmith P, Greenberg D (2000a) Induction of vascular endothelial growth factor and hypoxia-inducible factor-1\u03b1 by global ischemia in rat brain. Neuroscience 99:577\u2013585. https:\/\/doi.org\/10.1016\/s0306-4522(00)00207-4","journal-title":"Neuroscience"},{"key":"1237_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s0306-4522(00)00331-6","volume":"100","author":"K Jin","year":"2000","unstructured":"Jin K, Mao X, Nagayama T, Goldsmith P, Greenberg D (2000b) Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3\u2032-kinase\/Akt signaling by global cerebral ischemia in the rat. Neuroscience 100:713\u2013717. https:\/\/doi.org\/10.1016\/s0306-4522(00)00331-6","journal-title":"Neuroscience"},{"key":"1237_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0306-4522(01)00154-3","volume":"108","author":"K Jin","year":"2001","unstructured":"Jin K, Mao X, Batteur S, McEachron E, Leahy A, Greenberg D (2001) Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 108:351\u2013358. https:\/\/doi.org\/10.1016\/s0306-4522(01)00154-3","journal-title":"Neuroscience"},{"key":"1237_CR24","first-page":"208","volume-title":"Seminars in neurology","author":"M Katan","year":"2018","unstructured":"Katan M, Luft A (2018) Global burden of stroke. Seminars in neurology. Thieme Medical Publishers, New York, pp 208\u2013211"},{"key":"1237_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11060-018-2823-7","volume":"138","author":"V Kepe","year":"2018","unstructured":"Kepe V, Scafoglio C, Liu J, Yong WH, Bergsneider M, Huang S-C, Barrio JR, Wright EM (2018) Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas. J Neurooncol 138:557\u2013569. https:\/\/doi.org\/10.1007\/s11060-018-2823-7","journal-title":"J Neurooncol"},{"key":"1237_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4103\/1673-5374.206632","volume":"12","author":"M Khan","year":"2017","unstructured":"Khan M, Khan H, Singh I, Singh AK (2017) Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury. Neural Regen Res 12:696. https:\/\/doi.org\/10.4103\/1673-5374.206632","journal-title":"Neural Regen Res"},{"key":"1237_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/blood-2013-09-51274","volume":"123","author":"Y-W Kim","year":"2014","unstructured":"Kim Y-W, Byzova TV (2014) Oxidative stress in angiogenesis and vascular disease. Blood 123:625\u2013631. https:\/\/doi.org\/10.1182\/blood-2013-09-51274","journal-title":"Blood"},{"key":"1237_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-med-042017-094221","volume":"70","author":"CK Kramer","year":"2019","unstructured":"Kramer CK, Zinman B (2019) Sodium\u2013glucose cotransporter\u20132 (SGLT-2) inhibitors and the treatment of type 2 diabetes. Annu Rev Med 70:323\u2013334. https:\/\/doi.org\/10.1146\/annurev-med-042017-094221","journal-title":"Annu Rev Med"},{"key":"1237_CR29","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1371\/journal.pone.0000156","volume":"2","author":"HJ Lee","year":"2007","unstructured":"Lee HJ, Kim KS, Park IH, Kim SU (2007) Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLloS ONE 2:e156. https:\/\/doi.org\/10.1371\/journal.pone.0000156","journal-title":"PLloS ONE"},{"key":"1237_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainres.2010.08.012","volume":"1356","author":"J Li","year":"2010","unstructured":"Li J, Han B, Ma X, Qi S (2010) The effects of propofol on hippocampal caspase-3 and Bcl-2 expression following forebrain ischemia\u2013reperfusion in rats. Brain Res 1356:11\u201323. https:\/\/doi.org\/10.1016\/j.brainres.2010.08.012","journal-title":"Brain Res"},{"key":"1237_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Xue M, Li X, Han F, Liu X, Xu L, Lu Y, Cheng Y, Li T (2019) SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol 18:15. https:\/\/doi.org\/10.1186\/s12933-019-0816-2","journal-title":"Cardiovasc Diabetol"},{"key":"1237_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3892\/br.2013.153","volume":"1","author":"G Liu","year":"2013","unstructured":"Liu G, Wang T, Wang T, Song J, Zhou Z (2013) Effects of apoptosis\u2013related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomed Rep 1:861\u2013867. https:\/\/doi.org\/10.3892\/br.2013.153","journal-title":"Biomed Rep"},{"key":"1237_CR101","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1369\/0022155411412599","volume":"59","author":"E Maae","year":"2011","unstructured":"Maae E, Nielsen M, Steffensen KD, Jakobsen EH, Jakobsen A, S\u00f8rensen FB (2011) Estimation of immunohistochemical expression of VEGF in ductal carcinomas of the breast. J Histochem Cytochem 59:750\u2013760. https:\/\/doi.org\/10.1369\/0022155411412599","journal-title":"J Histochem Cytochem"},{"key":"1237_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.nbd.2003.08.020","volume":"14","author":"D Mu","year":"2003","unstructured":"Mu D, Jiang X, Sheldon RA, Fox CK, Hamrick SE, Vexler ZS, Ferriero DM (2003) Regulation of hypoxia-inducible factor 1\u03b1 and\ninduction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol Dis 14:524\u2013534. https:\/\/doi.org\/10.1016\/j.nbd.2003.08.020","journal-title":"Neurobiol Dis"},{"key":"1237_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4161\/cam.3.2.8396","volume":"3","author":"D Navaratna","year":"2009","unstructured":"Navaratna D, Guo S, Arai K, Lo EH (2009) Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr 3:216\u2013223. https:\/\/doi.org\/10.4161\/cam.3.2.8396","journal-title":"Cell Adh Migr"},{"key":"1237_CR35","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00414-018-1893-","volume":"133","author":"S Oerter","year":"2019","unstructured":"Oerter S, F\u00f6rster C, Bohnert M (2019) Validation of sodium\/glucose cotransporter proteins in human brain as a potential marker for temporal narrowing of the trauma formation. Int J Legal Med 133:1107\u20131114. https:\/\/doi.org\/10.1007\/s00414-018-1893-","journal-title":"Int J Legal Med"},{"key":"1237_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.nbd.2011.10.020","volume":"45","author":"ME Ogle","year":"2012","unstructured":"Ogle ME, Gu X, Espinera AR, Wei L (2012) Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1\u03b1. Neurobiol Dis 45:733\u2013742. https:\/\/doi.org\/10.1016\/j.nbd.2011.10.020","journal-title":"Neurobiol Dis"},{"key":"1237_CR37","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1055\/s-0034-1395609","volume":"47","author":"A Ojima","year":"2015","unstructured":"Ojima A, Matsui T, Nishino Y, Nakamura N, Yamagishi S (2015) Empagliflozin, an inhibitor of sodium-glucose cotransporter 2 exerts anti-inflammatory and antifibrotic effects on experimental diabetic nephropathy partly by suppressing AGEs-receptor axis. Horm Metab Res 47:686\u2013692. https:\/\/doi.org\/10.1055\/s-0034-1395609","journal-title":"Horm Metab Res"},{"key":"1237_CR38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00429-018-1800-4","volume":"224","author":"S Otsuka","year":"2019","unstructured":"Otsuka S, Sakakima H, Terashi T, Takada S, Nakanishi K, Kikuchi K (2019) Preconditioning exercise reduces brain damage and neuronal apoptosis through enhanced endogenous 14-3-3\u03b3 after focal brain ischemia in rats. Brain Struct Funct 224:727\u2013738. https:\/\/doi.org\/10.1007\/s00429-018-1800-4","journal-title":"Brain Struct Funct"},{"key":"1237_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/00005072-199906000-00010","volume":"58","author":"KH Plate","year":"1999","unstructured":"Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C (1999) Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol 58:654\u2013666. https:\/\/doi.org\/10.1097\/00005072-199906000-00010","journal-title":"J Neuropathol Exp Neurol"},{"key":"1237_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1471-4159.1997.69010084.x","volume":"69","author":"R Poppe","year":"1997","unstructured":"Poppe R, Karbach U, Gambaryan S, Wiesinger H, Lutzenburg M, Kraemer M, Witte OW, Koepsell H (1997) Expression of the Na+-D\u2010glucose cotransporter SGLT1 in neurons. J Neurochem 69:84\u201394. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.69010084.x","journal-title":"J Neurochem"},{"key":"1237_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1570161115666161104095522","volume":"15","author":"D Radak","year":"2017","unstructured":"Radak D, Katsiki N, Resanovic I, Jovanovic A, Sudar-Milovanovic E, Zafirovic S, Mousad A, Isenovic SR (2017) Apoptosis and acute brain ischemia in ischemic stroke. Curr Vasc Pharmacol 15:115\u2013122.\nhttps:\/\/doi.org\/10.2174\/1570161115666161104095522","journal-title":"Curr Vasc Pharmacol"},{"key":"1237_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","volume":"9","author":"S Ramakrishnan","year":"2014","unstructured":"Ramakrishnan S, Anand V, Roy S (2014) Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol 9:142\u2013160. https:\/\/doi.org\/10.1007\/s11481-014-9531-7","journal-title":"J Neuroimmune Pharmacol"},{"key":"1237_CR43","unstructured":"Robinson PJ, Hack C, Merrill EA, Mattie DR (2017) Mathematical model of HIF-1 alpha pathway, oxygen transport and hypoxia. Henry M. Jackson Foundation For the Advancement of Military Medicine Wright-Patterson AFB"},{"key":"1237_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/107327480200902S05","volume":"9","author":"LS Rosen","year":"2002","unstructured":"Rosen LS (2002) Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control 9:36\u201344. https:\/\/doi.org\/10.1177\/107327480200902S05","journal-title":"Cancer Control"},{"key":"1237_CR45","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/STROKEAHA.111.620088","volume":"43","author":"M-G Ryou","year":"2012","unstructured":"Ryou M-G, Liu R, Ren M, Sun J, Mallet RT, Yang S-H (2012) Pyruvate protects the brain against ischemia\u2013reperfusion injury by activating the erythropoietin signaling pathway. Stroke 43:1101\u20131107. https:\/\/doi.org\/10.1161\/STROKEAHA.111.620088","journal-title":"Stroke"},{"key":"1237_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","volume":"333","author":"P Sanguanmoo","year":"2017","unstructured":"Sanguanmoo P, Tanajak P, Kerdphoo S, Jaiwongkam T, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2017) SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicol Appl Pharmacol 333:43\u201350. https:\/\/doi.org\/10.1016\/j.taap.2017.08.005","journal-title":"Toxicol Appl Pharmacol"},{"key":"1237_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11010-016-2885-9","volume":"426","author":"SK Sanganalmath","year":"2017","unstructured":"Sanganalmath SK, Gopal P, Parker JR, Downs RK, Parker JC, Dawn B (2017) Global cerebral ischemia due to circulatory arrest: insights into cellular pathophysiology and diagnostic modalities. Mol Cell Biochem 426:111\u2013127. https:\/\/doi.org\/10.1007\/s11010-016-2885-9","journal-title":"Mol Cell Biochem"},{"key":"1237_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/cpdd.16","volume":"2","author":"L Seman","year":"2013","unstructured":"Seman L, Macha S, Nehmiz G, Simons G, Ren B, Pinnetti S, Woerle HJ, Dugi K (2013) Empagliflozin (BI 10773), a potent and selective SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects. Clin Pharmacol Drug Dev 2:152\u2013161. https:\/\/doi.org\/10.1002\/cpdd.16","journal-title":"Clin Pharmacol Drug Dev"},{"key":"1237_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/jcbfm.2008.120","volume":"29","author":"JM Simard","year":"2009","unstructured":"Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, Gerzanich V (2009) Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 29:317\u2013330. https:\/\/doi.org\/10.1038\/jcbfm.2008.120","journal-title":"J Cereb Blood Flow Metab"},{"key":"1237_CR50","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1172\/JCI17977","volume":"111","author":"Y Sun","year":"2003","unstructured":"Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111:1843\u20131851. https:\/\/doi.org\/10.1172\/JCI17977","journal-title":"J Clin Invest"},{"key":"1237_CR51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2174\/1389203719666180104113937","volume":"19","author":"V Theis","year":"2018","unstructured":"Theis V, Theiss C (2018) VEGF-a stimulus for neuronal development and regeneration in the CNS and PNS. Curr Protein Pept Sci 19:589\u2013597. https:\/\/doi.org\/10.2174\/1389203719666180104113937","journal-title":"Curr Protein Pept Sci"},{"key":"1237_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1463-1326.2011.01518.x","volume":"14","author":"L Thomas","year":"2012","unstructured":"Thomas L, Grempler R, Eckhardt M, Himmelsbach F, Sauer A, Klein T, Eickelmann P, Mark M (2012) Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats. Diabetes Obes Metab 14:94\u201396. https:\/\/doi.org\/10.1111\/j.1463-1326.2011.01518.x","journal-title":"Diabetes Obes Metab"},{"key":"1237_CR53","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","volume":"61","author":"L Uthman","year":"2018","unstructured":"Uthman L, Baartscheer A, Bleijlevens B, Schumacher CA, Fiolet JW, Koeman A, Jancev M, Hollmann MW, Weber NC, Coronel R (2018) Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering of cytosolic Na+ and vasodilation. Diabetologia 61:722\u2013726. https:\/\/doi.org\/10.1007\/s00125-017-4509-7","journal-title":"Diabetologia"},{"key":"1237_CR55","doi-asserted-by":"publisher","first-page":"A051","DOI":"10.1161\/hyp.74.suppl_1.051","volume":"74","author":"S Wang","year":"2019","unstructured":"Wang S, Fan F (2019) Oral antihyperglycemic therapy with a SGLT2 inhibitor reverses cognitive impairments in elderly diabetics. Hypertension 74:A051\u2013A051. https:\/\/doi.org\/10.1161\/hyp.74.suppl_1.051","journal-title":"Hypertension"},{"key":"1237_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.exger.2017.12.010","volume":"102","author":"L Wang","year":"2018","unstructured":"Wang L, Wang F, Liu S, Yang X, Yang J, Ming D (2018) VEGF attenuates 2-VO induced cognitive impairment and neuronal injury associated with the activation of PI3K\/Akt and Notch1 pathway. Exp Gerontol 102:93\u2013100. https:\/\/doi.org\/10.1016\/j.exger.2017.12.010","journal-title":"Exp Gerontol"},{"key":"1237_CR56","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1152\/physrev.00055.2009","volume":"91","author":"EM Wright","year":"2011","unstructured":"Wright EM, Loo DD, Hirayama BA (2011) Biology of human sodium glucose transporters. Physiol Rev 91:733\u2013794. https:\/\/doi.org\/10.1152\/physrev.00055.2009","journal-title":"Physiol Rev"},{"key":"1237_CR57","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10557-018-6837-3","volume":"32","author":"Y Ye","year":"2018","unstructured":"Ye Y, Jia X, Bajaj M, Birnbaum Y (2018) Dapagliflozin attenuates Na+\/H+ exchanger-1 in cardiofibroblasts via AMPK activation. Cardiovasc Drugs Ther 32:553\u2013558. https:\/\/doi.org\/10.1007\/s10557-018-6837-3","journal-title":"Cardiovasc Drugs Ther"},{"key":"1237_CR58","doi-asserted-by":"publisher","first-page":"C240","DOI":"10.1152\/ajpcell.00317.2012","volume":"304","author":"AS Yu","year":"2012","unstructured":"Yu AS, Hirayama BA, Timbol G, Liu J, Diez-Sampedro A, Kepe V, Satyamurthy N, Huang S-C, Wright EM, Barrio JR (2012) Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol 304:C240\u2013C247. https:\/\/doi.org\/10.1152\/ajpcell.00317.2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"1237_CR59","doi-asserted-by":"publisher","first-page":"526814","DOI":"10.1074\/jbc.M113.526814","volume":"M113","author":"JR Zapata-Morales","year":"2013","unstructured":"Zapata-Morales JR, Galicia-Cruz OG,\nFranco M, y Morales FM (2013) HIF-1\u03b1 diminishes SGLT1 and SGLT2 expression in renal epithelial tubular cells (LLC-PK1) under hypoxia. J Biol Chem M113:526814. https:\/\/doi.org\/10.1074\/jbc.M113.526814","journal-title":"J Biol Chem"},{"key":"1237_CR60","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1074\/jbc.M113.526814","volume":"289","author":"JR Zapata-Morales","year":"2014","unstructured":"Zapata-Morales JR, Galicia-Cruz OG, Franco M, y Morales FM (2014) Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) protein diminishes sodium glucose transport 1 (SGLT1) and SGLT2 protein expression in renal epithelial tubular cells (LLC-PK1) under hypoxia. J Biol Chem 289:346\u2013357. https:\/\/doi.org\/10.1074\/jbc.M113.526814","journal-title":"J Biol Chem"},{"key":"1237_CR61","first-page":"1532","volume":"116","author":"H Zhou","year":"2003","unstructured":"Zhou H, Ma Y, Zhou Y, Liu Z, Wang K, Chen G (2003) Effects of magnesium sulfate on neuron apoptosis and expression of caspase-3, bax and bcl-2 after cerebral ischemia-reperfusion injury. Chin Med J 116:1532\u20131534","journal-title":"Chin Med J"},{"key":"1237_CR62","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.kint.2018.05.002","volume":"94","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Nakano D, Guan Y, Hitomi H, Uemura A, Masaki T, Kobara H, Sugaya T, Nishiyama A (2018) A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice. Kidney Int 94:524\u2013535. https:\/\/doi.org\/10.1016\/j.kint.2018.05.002","journal-title":"Kidney Int"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-020-01237-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01237-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T08:04:11Z","timestamp":1621497851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-020-01237-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1237"],"URL":"https:\/\/doi.org\/10.1007\/s12272-020-01237-y","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"26 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}